2m 2m 2m 2m 2m 2m 2m
SERINA THERAP (SER)
NYSE
$2.84-$0.03 (-1.11%)
Price as of Aug 21, 2026 8:00 PM EDT- $72.9MMarket Cap
- -49.20%1-Year Change
- BiotechnologyIndustry
SERINA THERAP (SER)
$2.84-$0.03 (-1.11%)
SER | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.87 | ||
Change | +$0.22 (+8.30%) | ||
Open | $2.67 | ||
High | $2.87 | ||
Low | $2.62 | ||
Previous Close | $2.65 | ||
Volume | 46,107 | ||
30-Day Average Volume | 57,676 | ||
1-Week Change | 2.50% | ||
1-Month Change | 37.32% | ||
1-Year Change | -49.20% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 25.4M | ||
Total Assets | $25.8M | ||
Market Cap | $72.9M | ||
Enterprise Value | $53.0M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$6.4M | ||
Free Cash Flow | -$6.7M | ||
EBIT | -$6.4M | ||
EBITDA | -$6.3M | ||
Net Working Capital | $21.3M | ||
EPS | -$0.55 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -5 | ||
PEG | -1 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue